Article thumbnail
Location of Repository

Immunobiotic Lactobacillus rhamnosus strains differentially modulate antiviral immune response in intestinal epithelial and antigen presenting cells

By Julio Cesar Villena, Eriko Chiba, María Guadalupe Vizoso Pinto, Yohsuke Tomosada, Takuya Takahashi, Takuya Ishizuka, Takuya Aso, Maria Susana Salva, Gladis Susana Alvarez and Haruki Kitazawa

Abstract

Background: previous findings suggested that Lactobacillus rhamnosus CRL1505 is able to increase resistance of children to intestinal viral infections. However, the intestinal cells, cytokines and receptors involved in the immunoregulatory effect of this probiotic strain have not been fully characterized. Objective: we aimed to gain insight into the mechanisms involved in the immunomodulatory effect of the CRL1505 strain and therefore evaluated in vitro the crosstalk between L. rhamnosus CRL1505, porcine intestinal epithelial cells (IECs) and antigen presenting cells (APCs) from swine Peyer?s patches in order to deepen our knowledge about the mechanisms, through which this strain may help preventing viral diarrhoea episodes. Results: L. rhamnosus CRL1505 was able to induce IFN?α and ?β in IECs and improve the production of type I IFNs in response to poly(I:C) challenge independently of Toll-like receptor (TLR)-2 or TLR9 signalling. In addition, the CRL1505 strain induced mRNA expression of IL-6 and TNF-α via TLR2 in IECs. Furthermore, the strain significantly increased surface molecules expression and cytokine production in intestinal APCs. The improved Th1 response induced by L. rhamnosus CRL1505 was triggered by TLR2 signalling and included augmented expression of MHC-II and co-stimulatory molecules and expression of IL-1β, IL-6, and IFN-γ in APCs. IL-10 was also significantly up-regulated by CRL1505 in APCs. Conclusions: it was recently reviewed the emergence of TLR agonists as new ways to transform antiviral treatments by introducing panviral therapeutics with less adverse effects than IFN therapies. The use of L. rhamnosus CRL1505 as modulator of innate immunity and inductor of antiviral type I IFNs, IFN-γ, and regulatory IL-10 clearly offers the potential to overcome this challenge

Topics: LACTOBACILLUS RHAMNOSUS, POLY(I:C), ANTIVIRAL IMMUNITY, PIE CELLS, INTESTINAL ANTIGEN PRESENTING CELLS, TLR2, Inmunología, Medicina Básica, CIENCIAS MÉDICAS Y DE LA SALUD
Publisher: BioMed Central
Year: 2014
DOI identifier: 10.1186/1471-2180-14-126
OAI identifier: oai:ri.conicet.gov.ar:11336/102106
Provided by: CONICET Digital
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://hdl.handle.net/11336/10... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.